Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis

International Journal of Cancer. Journal International Du Cancer
Rosalind C Gregory-BassWinston E Thompson

Abstract

Current approaches to the treatment of ovarian cancer are limited because of the development of resistance to chemotherapy. Prohibitin (Phb1) is a possible candidate protein that contributes to development of drug resistance, which could be targeted in neoplastic cells. Phb1 is a highly conserved protein that is associated with a block in the G0/G1 phase of the cell cycle and also with cell survival. Our study was designed to determine the role of Phb1 in regulating cellular growth and apoptosis in ovarian cancer cells. Our results showed that Phb1 content is differentially overexpressed in papillary serous ovarian carcinoma and endometrioid ovarian adenocarcinoma when compared to normal ovarian epithelium and was inversely related to Ki67 expression. Immunofluorescence microscopy and Western analyses revealed that Phb1 is primarily associated with the mitochondria in ovarian cancer cells. Over-expression of Phb1 by adenoviral Phb1 infection resulted in an increase in the percentage of ovarian cancer cells accumulating at G0/G1 phase of the cell cycle. Treatment of ovarian cancer cells with staurosporine (STS) induced apoptosis in a time-dependent manner. Phb1 over-expression induced cellular resistance to STS via the intrinsic...Continue Reading

References

Nov 1, 1993·Journal of Cellular Physiology·A J RoskamsJ K McClung
Jan 1, 1993·Trends in Genetics : TIG·D M Black, E Solomon
Jan 1, 1996·Experimental Gerontology·R T Dell'OrcoX T Liu
Aug 26, 2000·The Journal of Biological Chemistry·T U HaS Maheswaran
Sep 24, 2002·The Journal of Biological Chemistry·Matthew G Vander HeidenCharles M Rudin
Jun 10, 2003·The Journal of Biological Chemistry·Marta Artal-SanzLeo G J Nijtmans
Jul 18, 2003·Cell Death and Differentiation·M Karbowski, R J Youle
Nov 12, 2003·Reproductive Biology and Endocrinology : RB&E·Michael FraserBenjamin K Tsang
Feb 18, 2004·Oncogene·Simon C GambleCharlotte L Bevan
Mar 19, 2004·Biology of Reproduction·Winston E ThompsonBenjamin K Tsang
May 14, 2004·The EMBO Journal·Sheng WangDouglas V Faller
Sep 21, 2004·Proteomics·Qing-Ye HeJen-Fu Chiu
Nov 5, 2004·Molecular Biology of the Cell·Takashi TatsutaThomas Langer
Jul 26, 2005·Nature Cell Biology·Krishnaraj RajalingamThomas Rudel
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingo B Runnebaum, Ansgar Brüning
May 23, 2006·Current Cancer Drug Targets·Christian KurzederHelmut Deissler
Sep 30, 2006·The Journal of Biological Chemistry·Katsumi KasashimaHitoshi Endo
Apr 13, 2007·Nature·Angelique W WhitehurstMichael A White
May 9, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Jesse CraigBenjamin K Tsang

❮ Previous
Next ❯

Citations

Oct 8, 2013·Apoptosis : an International Journal on Programmed Cell Death·Indrajit ChowdhuryRoland Matthews
Jun 15, 2010·Journal of Natural Medicines·Enos Tangke ArungFerry Sandra
May 30, 2013·Medical Oncology·Mohammad Zeeshan NajmSyed Akhtar Husain
Sep 2, 2011·Biochemistry·Srinivas R SripathiWan Jin Jahng
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nish PatelBruce R Zetter
May 13, 2010·Biomedical Research·Takashi MuraguchiShunichiro Kubota
Dec 29, 2011·Frontiers in Bioscience (Elite Edition)·Indrajit ChowdhuryWinston E Thompson
Dec 15, 2015·The Protein Journal·Srinivas R SripathiWan Jin Jahng
Jun 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Xi ZhuJinjun Shi
Dec 19, 2013·Journal of Cellular Physiology·Indrajit ChowdhuryKelwyn Thomas
Sep 17, 2015·Annals of the New York Academy of Sciences·Bao KongBenjamin K Tsang
Oct 1, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Yu-Huei LiuJung-Yaw Lin
Oct 26, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ning ZhongJinxiang Han
Sep 7, 2012·Journal of Proteomics·Virginia Sánchez-QuilesFernando J Corrales
Jun 21, 2015·Apoptosis : an International Journal on Programmed Cell Death·Ya-Ting PengLei Song
Feb 8, 2011·Biochimica Et Biophysica Acta·Arianne L Theiss, Shanthi V Sitaraman
Jan 19, 2013·Journal of Receptor and Signal Transduction Research·Tian-Biao Zhou, Yuan-Han Qin
Mar 31, 2016·Journal of Molecular Cell Biology·Yingjie XuBruce R Zetter
Apr 5, 2012·Journal of Proteome Research·Sofia WaldemarsonPeter James
Apr 3, 2018·Free Radical Research·Youngjin HanYong Sang Song
Feb 5, 2019·International Journal of Cancer. Journal International Du Cancer·Marcel V Alavi
Sep 19, 2008·Cancer·Grace K Dy, Alex A Adjei
Sep 5, 2013·International Journal of Oncology·Cong WangHong-Min Liu
Jun 28, 2014·International Journal of Oncology·Xia LiuFuqiang Yin
Sep 2, 2017·Expert Review of Proteomics·Yang WangQing-Yu He
Apr 30, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Li-Ying ZhangXin-Chen Zhang
Apr 22, 2017·Journal of Ovarian Research·Nour M El-EtrebyRadwaa Rashad
Dec 18, 2013·Oncology Reports·Xia LiuFuqiang Yin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis